MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS DEXTILE; MESH, SURGICAL, POLYMERIC

Model Number	DXT1510AR
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Abdominal Pain (1685); Bacterial Infection (1735); Diarrhea (1811); Encephalopathy (1833); Fatigue (1849); Headache (1880); Hearing Impairment (1881); Nausea (1970); Pain (1994); Tinnitus (2103); Dizziness (2194); Hernia (2240); Discomfort (2330); Depression (2361); Constipation (3274); Suicidal Ideation (4429); Unspecified Blood or Lymphatic problem (4434); Unspecified Eye / Vision Problem (4471); Unspecified Gastrointestinal Problem (4491); Sexual Dysfunction (4510); Unspecified Tissue Injury (4559); Decreased Appetite (4569); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581); Atrophy (4913)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
H6 ime e2402: weight loss, ejaculation disorders, testicular atrophy, blood disorders, hypogammaglobulinemia, prostatitis, dysautonomia, deterioration of general condition, anorexia, digestive disorders, weakened ejaculation.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a inguinal hernia.It was reported that after the implant, the patient experienced weight loss, loss of appetite, chronic fatigue, nausea, headaches, vision problems, hearing problems, tinnitus, dizziness, ejaculation disorders, testicular atrophy, blood disorders, hypogammaglobulinemia, abdominal pain, dysautonomia, deterioration of general condition, anorexia, digestive disorders, constipation, diarrhea, sexual disturbances, weakened ejaculation, pain, depressive syndrome, recurrence, discomfort, prostatitis, <(>&<)> suicidal thoughts.Post-operative patient treatment included ultrasound, hospitalization, mri, <(>&<)> anti-depressants.
Additional Manufacturer Narrative
Correction: h6 (added patient codes).Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Additional Manufacturer Narrative
Correction: updated 6da medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a inguinal hernia.It was reported that after the implant, the patient experienced weight loss, loss of appetite, chronic fatigue, nausea, headaches, vision problems, hearing problems, tinnitus, dizziness, ejaculation disorders, testicular atrophy, blood disorders, hypogammaglobulinemia, abdominal pain, dysautonomia, deterioration of general condition, anorexia, digestive disorders, constipation, diarrhea, sexual disturbances, weakened ejaculation, pain, depressive syndrome, recurrence, discomfort, prostatitis, disability, myalgic encephalomyelitis, & suicidal thoughts.Post-operative patient treatment included ultrasound, hospitalization, mri, & anti-depressants.
Additional Manufacturer Narrative
Additional information: b2, b5, h6 (added patient and imf code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Additional Manufacturer Narrative
Correction: h6 (added patient codes) e2402: dysautonomia, anorexia, prostatitis, weight loss.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Additional Manufacturer Narrative
Additional info: b5, d4 (unique identifier (udi) #), h6 (patient codes).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an inguinal hernia.It was reported that after the implant, the patient experienced weight loss, loss of appetite, chronic fatigue, nausea, headaches, vision problems, hearing problems, tinnitus, dizziness, ejaculation disorders, testicular atrophy, blood disorders, hypogammaglobulinemia, abdominal pain, dysautonomia, deterioration of general condition, anorexia, digestive disorders, constipation, diarrhea, sexual disturbances, weakened ejaculation, pain, depressive syndrome, recurrence, discomfort, prostatitis, disability, myalgic encephalomyelitis, suicidal thoughts.Post-operative patient treatment included ultrasound, hospitalization, mri, anti-depressants.The patient claimed in an interview with an rtl radio host that the mesh implanted in them was contaminated with nosocomial bacterial and they stated they are "dying from exhaustion".
Additional Manufacturer Narrative
Correction added h6 ime e2402: hypogammaglobulinemia.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.

• Brand Name: DEXTILE
• Common Device Name: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: mike bocchino ; 8200 coral sea st ne; mounds view, MN 55112-4391 ; 8006464633
• MDR Report Key: 18904886
• Report Number: 9615742-2024-00394
• Device Sequence Number: 7887350
• Product Code: FTL
• UDI-Device Identifier: 10884521726512
• UDI-Public: (01)10884521726512(17)280229(10)SXC0637X
• Combination Product (Y/N): N
• Initial Reporter Country: FR
• PMA/510(K) Number: K192443
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Consumer
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date (Section B): 02/02/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: DXT1510AR
• Device Catalogue Number: DXT1510AR
• Device Lot Number: SXC0637X
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 03/08/2024
• Supplement Date Received by Manufacturer: 03/08/2024; 03/20/2024; 06/24/2024; 11/22/2025; 12/03/2025; 01/16/2026; 01/28/2026
• Initial Report FDA Received Date: 03/14/2024
• Supplement Report FDA Received Date: 03/14/2024; 03/20/2024; 06/24/2024; 11/25/2025; 12/03/2025; 01/22/2026; 02/02/2026
• Date Device Manufactured: 03/09/2023
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention; Hospitalization; Disability
• Patient Sex: Unknown